Showing results (471-480 of 6,709) with videos related to

Sort By:
Pageof 671
Oncotargets and Therapy|March 14, 2019
Correlations of lncRNAs with cervical lymph node metastasis and prognosis of papillary thyroid carcinomaNa Li, Mingming Cui, Ping Yu, et al.
Oncotargets and Therapy|March 14, 2019
Ten years of research on the role of BVES/ POPDC1 in human disease: a reviewPing Han, Yu Lei, Dongxiao Li, et al.
Oncotargets and Therapy|March 14, 2019
Potent in vitro and xenograft antitumor activity of a novel agent, PV-10, against relapsed and refractory neuroblastomaLucy Swift, Chunfen Zhang, Tanya Trippett, et al.
Oncotargets and Therapy|March 14, 2019
Multiple extramedullary plasmacytomas of the trachea and pharyngeal tissue: a case report and literature reviewRu-Rong Tang, Yan Wang, Chao-Nan Liang, et al.
Oncotargets and Therapy|March 14, 2019
BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinomaWarut Pongsapich, Cheerasook Chongkolwatana, Naravat Poungvarin, et al.
Oncotargets and Therapy|March 14, 2019
Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinibShun Lu
Oncotargets and Therapy|December 17, 2021
LncRNA SNHG16 Regulates the Progress of Acute Myeloid Leukemia Through miR183-5p-FOXO1 Axis [Retraction]
Oncotargets and Therapy|November 24, 2021
The Study of Mucosal-Associated Invariant T Cells in Colon Cancer and Roles in Immune ActivitiesJuanfen Mo, Li Zheng, Zhenzhen Gao, et al.
Oncotargets and Therapy|August 15, 2019
MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1Li Tu, Xiang Long, Weidong Song, et al.
Oncotargets and Therapy|August 15, 2019
The LncRNA XIRP2-AS1 predicts favorable prognosis in colon cancerFengru Zhou, Feng Shen, Zhuojun Zheng, et al.
Pageof 671